Journal of Cancer Research and Therapeutics, 11, 653–654. doi:10.4103/0973-1482.138028 Kline, N. (Ed.). (2014). Essentials of pediatric oncology nursing: A core curriculum (4a ed.). Chicago, IL: Association of Pediatric Hematology/Oncology Nurses. Kobya Bulut, H. e Güdücü Tüfekci, F. (2016). Honey prevents oral mucositis in children undergoing chemotherapy: A quasi- experimental study with a control group. Complementary Therapies in Medicine, 29, 132–140. doi:10.1016/j.ctim.2016.09.018 Kortmann, R. D., Kühl, J., Timmermann, B., Mittler, U., Urban, C., Budach, V., . . . Bamberg, M. (2000). Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT ’91. International Journal of Radiation Oncology, Biology, Physics, 46 (2), 269–279. doi:10.1016/ S0360-3016(99)00369-7 Kuiken, N. S., Rings, E. H. e Tissing, W. J. (2015). Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients. Critical Reviews in Oncology/Hematology, 94 (1), 87–97. doi:10.1016/j.critrevonc.2014.12.009 Lacouture, M. E., Anadkat, M. J., Bensadoun, R. J., Bryce, J., Chan, A., Epstein, J. B., . . . MASCC Skin Toxicity Study Group. (2011). Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Supportive Care in Cancer, 19 (8), 1079-1095. doi:10.1007/s00520-011-1197-6 Ladas, E. J., Bhatia, M., Chen, L., Sandler, E., Petrovic, A., Berman, D. M., . . . Nieder, M. (2016). The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplantation, 51 (2), 262–266. doi:10.1038/bmt.2015.275 Ladas, E. J., Post-White, J., Hawks, R. e Taromina, K. (2006). Evidence for symptom management in the child with cancer. Journal of Pediatric Hematology and Oncology, 28 (9), 601–615. doi:10.1097/01. mph.0000212989.26317.52 Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., . . . The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). (2014). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 120 (10), 1453-1461. doi:10.1002/cncr.25892 Lambertini, M., Ceppi, M., Poggio, F., Peccatori, F. A., Azim, H. A., Ugolini, D., . . . Del Mastro, L. (2015). Ovarian suppression using luteinizing hormone–releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: A meta-analysis of randomized studies. Annals of Oncology, 26, 2408–2419. doi:10.1093/annonc/mdv374 Landier, W. (2016). Ototoxicity and cancer therapy. Cancer, 122, 1647– 1658. doi:10.1002/cncr.29779 Leise, M. D., Poterucha, J. J. e Talwalkar, J. A. (2014). Drug-induced liver injury. Mayo Clinic Proceedings, 89 (1), 95–106. doi:10.1016/j. mayocp.2013.09.016 Lexicomp. (2013). Lexicomp Online, Pediatric and Neonatal Lexi-Drugs Online . Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc. Li, H. C., Chung, O. K., Tam, C. J. e Chiu S. Y. (2015). Effective prevention and management of tumor lysis syndrome in children with cancer: The important contributions of pediatric oncology nurses. Journal of Pediatric Oncology Nursing, 32 (4), 209-218. doi:10.1177/1043454214555551 Lieberman, L., Petraszko, T., Yi, Q. L., Hannach, B. e Skeate, R. (2014). Transfusion-related lung injury in children: A case series and review of the literature. Transfusion, 54 (1), 57–64. doi:10.1111/trf.12249 Lim, K., Yoon, H., Kang, Y. A., Lee, K., Kim, J. H., Bang, S. M., . . . Lee, J. S. (2010). Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine,
and prednisone (CHOP) regimen plus rituximab. Korean Journal of Internal Medicine, 25 (1), 86–92. doi:10.3904/kjim.2010.25.1.86 Linabery, A. M., Li, W., Roesler, M. A., Spector, L. G., Gamis, A. S., Olshan, A. F., . . . Ross, J. A. (2015). Immune-related conditions and acute leukemia in children with Down syndrome: A Children’s Oncology Group report. Cancer Epidemiology, Biomarkers and Prevention, 24 (2), 454–458. http://doi.org/10.1158/1055-9965. EPI-14-1181 Lipshultz, S. E., Miller, T. L., Lipsitz, S. R., Neuberg, D. S., Dahlberg, S. E., Colan, S. D., . . . Sallan, S. E. (2012). Continuous versus bolus infusion of doxorubicin in children with ALL: Long-term cardiac outcomes. Pediatrics, 130 (6), 1003–1011. doi:10.1542/peds.2012-0727 Lipshultz, S. E., Miller, T. L., Scully, R. E., Lipsitz, S. R., Rifai, N., Silverman, L. B., . . . Sallan, S. E. (2012). Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: Associations with long-term echocardiographic outcomes. Journal of Clinical Oncology, 30 (10), 1042-1049. doi:10.1200/JCO.2010.30.3404 Lipshultz, S. E., Sambatakos, P., Maguire, M., Karnik, R., Ross, S. W., Franco, V. I. e Miller, T. L. (2014). Cardiotoxicity and cardioprotection in childhood cancer. Acta Haematologica, 132 (3–4), 391–399. doi:10.1159/000360238 Lisi, D. M. (2016). Drug-induced liver injury: An overview. US Pharmacist, 41 (12), 30–34. Extraído de: www.uspharmacist.com/ article/druginduced-liver-injury-an-overview Liu, C., Yang, W., Devidas, M., Cheng, C., Pei, D., Smith, C., . . . Relling, M. V. (2016). Clinical and genetic risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia. Journal of Clinical Oncology, 34 (18), 2133-2140. doi:10.1200/JCO.2015.64.5812 Lopes-Junior, L. C., Bomfim, E. O., Nascimento, L. C., Nunes, M. D., Pereira-da-Silva, G. e Lima, R. A. (2016). Non-pharmacological interventions to manage fatigue and psychological stress in children and adolescents with cancer: An integrative review. European Journal of Cancer Care, 25 (6), 921–935. doi:10.1111/ecc.12381 Lupu, I., Voiculescu, N., Bacalbasa, N., Cojocaru, I., Vrancian, V. e Giurcaneanu, C. (2016). Cutaneous complications of molecular targeted therapy used in oncology. Journal of Medicine and Life, 9 (1), 19–25. Extraído de: www.ncbi.nlm.nih.gov/pmc/articles/ PMC5152604 Magge, R. S. e DeAngelis, L. M. (2015). The double-edged sword: Neurotoxicity of chemotherapy. Blood Reviews, 29 (2), 93–100. doi:10.1016/j.bire.2014.09.012 Mahler, L. J., DiBlasi, R., Perez, A., Gaspard, J. e McCauley, D. (2017). On-body injector: An administration device for pegfilgrastim. Clinical Journal of Oncology Nursing, 21 (1), 121-122. doi:10.1188/17. CJON.121-122 Maloney, K. e Denno, M. (2011). Tumor lysis syndrome: Prevention and detection to enhance patient safety. Clinical Journal of Oncology Nursing, 15 (6), 601-603. doi:10.1188/11.CJON.601-603 Marx, W. M., Teleni, L., McCarthy, A. L., Vitetta, L., McKavanagh, D., Thomson, D. e Isenring, E. (2013). Ginger ( Zingiber officinale ) and chemotherapy-induced nausea and vomiting: A systematic literature review. Nutrition Reviews, 71 (4), 245–254. doi:10.1111/nure.12016 Matz, E. L. e Hsieh, M. H. (2017). Review of advances in uroprotective agents for cyclophosphamide and ifosfamide induced hemorrhagic cystitis. Urology, 100, 16–19. doi:10.1016/j.urology.2016.07.030 Mazlum, S., Chaharsoughi, N. T., Banihashem, A. e Vashani, H. B. (2013). The effect of massage therapy on chemotherapy-induced nausea and vomiting in pediatric cancer. Iranian Journal of Nursing and Midwifery Research, 18 (4), 280–284. McCutcheon, J. L., McClain, C. M., Puzanov, I. e Smith, T. A. (2014). Infectious colitis associated with ipilimumab therapy. Gastroenterology Research, 7 (1), 28–31. doi:10.14740/gr594e McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., . . . Clift, R. A. (1993). Veno-occlusive disease of the liver
Capítulo 8. Toxicidade e Tratamento de Sintomas 283
Powered by FlippingBook